Display options
Cite
Mullaguri N, Hepburn M, Newey CR, et al. Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus. J Neurosci Rural Pract. 2018;9(2):272-275doi: 10.4103/jnrp.jnrp_449_17.
Mullaguri, N., Hepburn, M., Newey, C. R., & Nattanmai, P. C. (2018). Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus. Journal of neurosciences in rural practice, 9(2), 272-275. https://doi.org/10.4103/jnrp.jnrp_449_17
Mullaguri, Naresh, et al. "Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus." Journal of neurosciences in rural practice vol. 9,2 (2018): 272-275. doi: https://doi.org/10.4103/jnrp.jnrp_449_17
Mullaguri N, Hepburn M, Newey CR, Nattanmai PC. Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus. J Neurosci Rural Pract. 2018 Apr-Jun;9(2):272-275. doi: 10.4103/jnrp.jnrp_449_17. PMID: 29725183; PMCID: PMC5912038.
Copy Download .nbib Format: NLM
Share it on

J Neurosci Rural Pract. 2018 Apr-Jun;9(2):272-275. doi: 10.4103/jnrp.jnrp_449_17.

Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus.

Journal of neurosciences in rural practice

Naresh Mullaguri, Madihah Hepburn, Christopher Ryan Newey, Premkumar Chandrasekharan Nattanmai

Affiliations

  1. Cerebrovascular Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  2. Department of Neurology, University of Missouri, Columbia, MO, USA.
  3. Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

PMID: 29725183 PMCID: PMC5912038 DOI: 10.4103/jnrp.jnrp_449_17

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinicoradiological syndrome that occurs due to dysfunction of cerebrovascular autoregulation. It is characterized by recurrent thunderclap headache from cerebral vasoconstriction which can cause ischemic infarction, spontaneous intraparenchymal and subarachnoid hemorrhage. This syndrome can be triggered by a variety of etiologies including medications, infectious, and inflammatory conditions. The diagnosis is often delayed due to unawareness among the health-care providers and delayed neuroimaging evidence of vasoconstriction with or without ischemic and/or hemorrhagic infarction. Status migrainosus is a prevalent condition requiring emergency room visits and inpatient admission. Thus, patients with RCVS can be easily misdiagnosed with migraine. We report a patient with RCVS misdiagnosed as status migrainosus with visual aura, treated with intravenous dihydroergotamine with worsening of cerebral vasoconstriction and lead to ischemic and hemorrhagic complications. We discuss this complication and provide guidance on differentiating between migraine and RCVS.

Keywords: Dihydroergotamine; intracerebral hemorrhage; migraine; reversible cerebral vasoconstriction syndrome; vasculopathy

Conflict of interest statement

There are no conflicts of interest.

References

  1. JAMA Neurol. 2014 Mar;71(3):368 - PubMed
  2. Emerg Med Clin North Am. 2009 Feb;27(1):71-87, viii - PubMed
  3. J Headache Pain. 2009 Aug;10 (4):295-8 - PubMed
  4. Stroke. 2016 Jul;47(7):1742-7 - PubMed
  5. Brain. 2007 Dec;130(Pt 12):3091-101 - PubMed
  6. J Headache Pain. 2005 Sep;6(4):287-9 - PubMed
  7. Headache. 2016 Apr;56(4):645-56 - PubMed
  8. Stroke. 2010 Nov;41(11):2505-11 - PubMed
  9. Headache. 2015 May;55(5):739-47 - PubMed
  10. Headache. 2016 Apr 8;:null - PubMed
  11. Headache. 2012 Apr;52(4):707-14 - PubMed
  12. Headache. 2016 Apr;56(4):657-73 - PubMed

Publication Types